These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34422846)

  • 21. The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.
    Emminger W; Hernández MD; Cardona V; Smeenk F; Fogh BS; Calderon MA; de Blay F; Backer V
    Int Arch Allergy Immunol; 2017; 174(1):35-44. PubMed ID: 28950268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
    Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
    J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An assessment of the sublingual immunotherapy with Dermatophagoides farinae on asthma control level and pulmonary function of allergic asthma and rhinitis in adult patient].
    Liu W; Jiang H; Pu H; Pi JT; Long Y; Zhang YL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 33(9):850-854. PubMed ID: 31446703
    [No Abstract]   [Full Text] [Related]  

  • 24. New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ
    Vitiello G; Maltagliati L; Rossi O
    Clin Mol Allergy; 2020; 18():10. PubMed ID: 32536827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
    Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
    J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. House dust mite sublingual immunotherapy in allergic rhinitis.
    Cho SW; Han DH; Kim JW; Kim DY; Rhee CS
    Immunotherapy; 2018 Jun; 10(7):567-578. PubMed ID: 29562802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of sublingual immunotherapy with Dermatophagoides farinae drops in preschool and school-age children with allergic asthma and allergic rhinitis].
    Chen S; Wang L; Liao F; Zeng X; Xing QB; Chen B; Lin XZ
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):831-5. PubMed ID: 24484557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
    Richards JR; Stumpf JL
    Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation for sublingual immunotherapy of allergic asthma and atopic rhinitis with Dermatophagoides Farinae Drops].
    Cao LF; Lu Q; Gu HL; Chen YP; Zhang Y; Lu M; Qian YQ; Li L; Xu YP
    Zhonghua Er Ke Za Zhi; 2007 Oct; 45(10):736-41. PubMed ID: 18211754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of house dust mite sublingual immunotherapy in children with allergic rhinitis and asthma].
    Chen S; Zeng X; Wang L; Chen B; Chen L; Wu S; Liao F; Feng X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 50(8):627-31. PubMed ID: 26696198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases.
    Ferrando M; Bagnasco D; Passa-Lacqua G; Puggioni F; Varricchi G; Canonica GW
    Curr Pharm Biotechnol; 2017; 18(5):378-383. PubMed ID: 28413977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
    Demoly P; Emminger W; Rehm D; Backer V; Tommerup L; Kleine-Tebbe J
    J Allergy Clin Immunol; 2016 Feb; 137(2):444-451.e8. PubMed ID: 26292778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study.
    Bahçeciler NN; Işik U; Barlan IB; Başaran MM
    Pediatr Pulmonol; 2001 Jul; 32(1):49-55. PubMed ID: 11416876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Retrospective Cohort Study of Sublingual Immunotherapy with Standardized Dermatophagoides farinae Drops for Allergic Rhinitis.
    Ma X; Zhang Y; Gu X; Wu G; Liu J; Lu J; Yang H
    Adv Ther; 2021 May; 38(5):2315-2322. PubMed ID: 33740216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens.
    Trebuchon F; Lhéritier-Barrand M; David M; Demoly P
    Clin Transl Allergy; 2014; 4():15. PubMed ID: 24910771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. House dust mite allergen immunotherapy for monosensitized versus polysensitized patients with allergic rhinitis: A systematic review and meta-analysis.
    Phinyo P; Krikeerati T; Wongyikul P; Lao-Araya M; Thongngarm T
    Asian Pac J Allergy Immunol; 2022 Dec; 40(4):337-352. PubMed ID: 36278778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients.
    Chen H; Gong GQ; Ding M; Dong X; Sun YL; Wan L; Gao YD
    Front Allergy; 2021; 2():810133. PubMed ID: 35386972
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.